Creo Medical Group (CREO)

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

  • Change Today:
  • 52 Week High: 243.00
  • 52 Week Low: 68.00
  • Currency: UK Pounds
  • Shares Issued: 119.92m
  • Volume: 423
  • Market Cap: 250.64m
  • Beta: 0.31

CREO Overview

Medical device company focused on the development and commercialisation of minimally invasive surgical devices, by bringing advanced energy to endoscopy

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart


Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-16 n/a (1.87) (5.00)p n/a n/a n/a n/a 0.0%
30-Jun-17 n/a (8.91) (13.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 n/a (9.31) (9.40)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.49 (11.16) (7.80)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

CREO Company Announcements

Spain & Benelux Framework Distribution Agreements 17-Oct-2018 07:00 RNS
Holding(s) in Company 12-Oct-2018 07:00 RNS
Holding(s) in Company 03-Oct-2018 12:14 RNS

Latest CREO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.


CREO Market Data

Currency UK Pounds
Share Price 209.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 243.00
52 Week Low 68.00
Volume 423
Shares Issued 119.92m
Market Cap 250.64m
Beta 0.31

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 19-Oct-2018

Time Volume / Share Price
08:22 423 @ 209.70p
08:04 20,000 @ 209.76p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees
COO Steve Morris

Top of Page